NOVOLIN 70-30 FLEXPEN U-100 (insulin nph human isophane/insulin regular, human)


Drug overview for NOVOLIN 70-30 FLEXPEN U-100 (insulin nph human isophane/insulin regular, human):

Generic name: insulin NPH human isophane/insulin regular, human (IN-su-lin HUE-man EYE-soe-fane 70/Regular 30)
Drug class: Intermediate-, Long-acting, and Combination Insulins
Therapeutic class: Endocrine

Insulin human is a biosynthetic protein that is structurally identical to endogenous insulin secreted by the beta cells of the human pancreas; commercially available insulin human preparations are classified as short-acting or intermediate-acting.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • NOVOLIN 70-30 FLEXPEN
    NOVOLIN 70-30 FLEXPEN
The following indications for NOVOLIN 70-30 FLEXPEN U-100 (insulin nph human isophane/insulin regular, human) have been approved by the FDA:

Indications:
Diabetes mellitus
Type 1 diabetes mellitus
Type 2 diabetes mellitus


Professional Synonyms:
Adult onset diabetes mellitus
Adult onset diabetes
Adult onset DM
Diabetes mellitus type 1
Diabetes mellitus type 2
Diabetes mellitus type II
Immune mediated diabetes mellitus
Insulin dependent diabetes mellitus
Insulin-dependent diabetes mellitus
Insulin-dependent DM
Juvenile diabetes
Juvenile onset DM
Juvenile-onset diabetes mellitus
Juvenile-onset diabetes
Ketosis-prone diabetes mellitus
Ketosis-prone diabetes
Ketosis-prone DM
Ketosis-resistant diabetes mellitus
Ketosis-resistant DM
Maturity onset diabetes mellitus
Maturity onset diabetes
Non-insulin dependent diabetes mellitus
Non-insulin-dependent diabetes mellitus
Type I diabetes mellitus
Type II diabetes mellitus